Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 5 mg, manufactured by Panacea Biotec Limited, India and the corresponding Reference Product (B): Prograf (Tacrolimus) Capsules 5 mg, manufactured by Astellas Pharma, Inc., USA in 36 normal, healthy, adult, male subjects under fed condition.
Epistemonikos ID: 49014d90ab97530835ad710bba8ca1716191708e
First added on: May 05, 2024